Literature DB >> 23194430

Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

Abstract

Entities: Disease Gene

Year: 2012 PMID： 23194430 PMCID： PMC3580421 DOI： 10.1186/gm388

Source DB: PubMed Journal: Genome Med ISSN： 1756-994X Impact factor: 11.117

× No keyword cloud information.

Correction

It has come to our attention that there is an error in the Acknowledgements section of our article [1]. The Acknowledgements section should read: SE is supported by the European Union through the IRG program. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at the project website [2]

1 in total

1. Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

Authors: Rotem Ben-Hamo; Sol Efroni
Journal: Genome Med Date: 2011-11-28 Impact factor: 11.117

1 in total

3 in total

Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

Correction

1. Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

1. MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype.

2. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.

3. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.